Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0J8JF
|
||||
| Former ID |
DIB014123
|
||||
| Drug Name |
RG-4934
|
||||
| Synonyms |
IL-17 huMAb (psoriatic arthritis), Roche
|
||||
| Drug Type |
Antibody
|
||||
| Indication | Arthritis [ICD9: 710-719; ICD10:M00-M25] | Discontinued in Phase 1 | [549128] | ||
| Company |
Roche Holding AG
|
||||
| Target and Pathway | |||||
| Target(s) | Interleukin-17 | Target Info | [549127] | ||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Interleukin signaling pathway | ||||
| Pathway Interaction Database | IL27-mediated signaling events | ||||
| IL23-mediated signaling events | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.